Global methane vaccine Target potential customers in cattle-intensive regions and large-scale dairy and beef operations by highlighting ArkeaBio's scalable methane vaccine as a low-cost, climate-focused solution with broad adoption potential across global supply chains.

Regulatory and funding momentum Leverage recent funding rounds and notable investors to approach grant programs, cooperative extensions, and sustainability funds that favor breakthrough agri-biotech solutions, positioning ArkeaBio as a vetted partner with proven investor confidence.

Strategic leadership Engage top-tier agritech and biopharma talent networks through the newly appointed CTO to emphasize advanced R&D capabilities, potential for rapid technology transfer, and credibility in securing large-tier farm and brand partnerships.

Brand and market alignment Align outreach with consumer and brand sustainability goals by underscoring the vaccine’s potential to reduce greenhouse gas emissions in livestock, appealing to retailers, processors, and consumer-facing brands seeking credible environmental credentials.

Proof of concept traction Highlight the recent proof-of-concept success and ongoing financing to desensitize risk for pilot programs with early adopters, enabling sales conversations around co-development, field trials, and conditional deployments with measurable emission reductions.